Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of QL0911 to prevention chemotherapy-induced
thrombocytopenia. Thrombocytopenia is a low number of platelets in the blood. Sometimes,
thrombocytopenia occurs as a side effect of chemotherapy treatments.